stockrowBruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) Operating cash flow
Bruker Corporation's operating cash flow for fiscal 2025 was $134.1M, down 46.6% from $251.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $341.8M. Over the past ten years it has ranged from $130.8M (fiscal 2016) to $350.1M (fiscal 2023); the current reading is higher than 18% of that period. Bruker Corporation ranks 18th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $134.1M | (46.64%) |
| FY2024 | $251.3M | (28.22%) |
| FY2023 | $350.1M | 27.59% |
| FY2022 | $274.4M | (2.83%) |
| FY2021 | $282.4M | (14.99%) |
| FY2020 | $332.2M | 55.67% |
| FY2019 | $213.4M | (10.97%) |
| FY2018 | $239.7M | 55.25% |
| FY2017 | $154.4M | 18.04% |
| FY2016 | $130.8M | (42.93%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $118.2M | — |
| Jun 2026 | −$77.4M | — |
| Mar 2026 | $71.2M | (69.02%) |
| Dec 2025 | $229.8M | — |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| GMED Globus Medical, Inc. compare | $925.9M |
| PODD Insulet Corporation compare | $509.0M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| BRKR Bruker Corporation | $341.8M |
| PEN Penumbra, Inc. compare | $261.0M |
| TXG 10x Genomics compare | $127.1M |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement